Table 1. Summary of reported distribution, level of expression, and methods of detection of LAT1 in human tumors.

Link to disease	Expression	Method of detection	Ref.
Uterine cervical carcinoma	Higher in invasive squamous cell carcinoma than in cervical intraepithelial neoplasia	Immunohistochemistry	(14,34)
Non-small cell lung cancer	Higher in patients with mediastinal lymph node metastases than in those without	Immunohistochemistry, quantitative real-time PCR	(4,27)
Oral cancer	High	Immunohistochemistry	(22,35,36)
Breast cancer	High	Immunohistochemistry, quantitative real time PCR, Western blotting	(37,38)
Renal cell carcinoma	High	Quantitative real-time PCR	(20)
Esophageal squamous cell carcinoma	High	Immunohistochemistry	(37)
Leukemic	High	Western blotting	(15)
Cholangiocarcinoma	High	Quantitative real- time PCR	(4)
Multiple myeloma	High, associated with increased proliferation	Immunohistochemistry	(39)
Malignant gliomas	Higher in infiltrating glioma cells than in cells located in the center of the tumor	Immunohistochemistry	(13)
Gastric cancer	High	Quantitative real-time PCR, Western blotting	(40)
Prostate cancer	High	Immunohistochemistry	(28,31,41)
Thymic carcinomas	High	Immunohistochemistry	(18)